These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 21917889)
1. Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1. Satoh M; Saito M; Takano T; Kasama Y; Nishimura T; Nishito Y; Hirata Y; Arai M; Sudoh M; Kai C; Kohara M; Tsukiyama-Kohara K J Infect Dis; 2011 Oct; 204(8):1172-80. PubMed ID: 21917889 [TBL] [Abstract][Full Text] [Related]
2. 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy. Saito M; Takano T; Nishimura T; Kohara M; Tsukiyama-Kohara K PLoS One; 2015; 10(4):e0124197. PubMed ID: 25875901 [TBL] [Abstract][Full Text] [Related]
3. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes. Takano T; Tsukiyama-Kohara K; Hayashi M; Hirata Y; Satoh M; Tokunaga Y; Tateno C; Hayashi Y; Hishima T; Funata N; Sudoh M; Kohara M J Hepatol; 2011 Sep; 55(3):512-521. PubMed ID: 21184787 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus promotes expression of the 3β-hydroxysterol δ24-reductase through Sp1. Saito M; Kohara M; Tsukiyama-Kohara K J Med Virol; 2012 May; 84(5):733-46. PubMed ID: 22431021 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Kim M; Shin D; Kim SI; Park M Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection. Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168 [TBL] [Abstract][Full Text] [Related]
7. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511 [TBL] [Abstract][Full Text] [Related]
8. Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences. Salem NE; Saito M; Kasama Y; Ozawa M; Kawabata T; Harada S; Suda H; Asonuma K; El-Gohary A; Tsukiyama-Kohara K Microbiol Immunol; 2013 Mar; 57(3):179-84. PubMed ID: 23277918 [TBL] [Abstract][Full Text] [Related]
9. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. Jarczak D; Korf M; Beger C; Manns MP; Krüger M FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication. Ando M; Korenaga M; Hino K; Ikeda M; Kato N; Nishina S; Hidaka I; Sakaida I Liver Int; 2008 Sep; 28(8):1158-66. PubMed ID: 18410284 [TBL] [Abstract][Full Text] [Related]
11. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065 [TBL] [Abstract][Full Text] [Related]
12. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells. Abe K; Ikeda M; Dansako H; Naka K; Shimotohno K; Kato N Virus Res; 2005 Jan; 107(1):73-81. PubMed ID: 15567036 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers. Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L. Yeh CT; Lai HY; Yeh YJ; Cheng JC Biochem Biophys Res Commun; 2008 Jul; 372(1):157-61. PubMed ID: 18474223 [TBL] [Abstract][Full Text] [Related]
16. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713 [TBL] [Abstract][Full Text] [Related]
17. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601 [TBL] [Abstract][Full Text] [Related]
19. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction. Negro F; Krawczynski K; Quadri R; Rubbia-Brandt L; Mondelli M; Zarski JP; Hadengue A Hepatology; 1999 Feb; 29(2):536-42. PubMed ID: 9918932 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Castillo I; Rodríguez-Iñigo E; Bartolomé J; de Lucas S; Ortíz-Movilla N; López-Alcorocho JM; Pardo M; Carreño V Gut; 2005 May; 54(5):682-5. PubMed ID: 15831916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]